statistiche ricercatore

Continente	#
NA - Nord America	1.055
AS - Asia	276
EU - Europa	211
SA - Sud America	45
Continente sconosciuto - Info sul continente non disponibili	40
AF - Africa	7
OC - Oceania	1
Totale	1.635

Nazione	#
US - Stati Uniti d'America	1.022
SG - Singapore	112
IT - Italia	67
VN - Vietnam	65
CN - Cina	51
BR - Brasile	32
DE - Germania	29
RU - Federazione Russa	28
CA - Canada	21
FI - Finlandia	17
GB - Regno Unito	15
FR - Francia	10
LV - Lettonia	8
SE - Svezia	8
ID - Indonesia	7
IN - India	6
JP - Giappone	6
AR - Argentina	5
BG - Bulgaria	5
KR - Corea	5
MX - Messico	5
NL - Olanda	5
BD - Bangladesh	4
IQ - Iraq	4
JO - Giordania	4
ZA - Sudafrica	4
HK - Hong Kong	3
PL - Polonia	3
UA - Ucraina	3
AT - Austria	2
CL - Cile	2
CO - Colombia	2
CZ - Repubblica Ceca	2
ES - Italia	2
JM - Giamaica	2
MY - Malesia	2
NP - Nepal	2
SV - El Salvador	2
AU - Australia	1
BY - Bielorussia	1
CH - Svizzera	1
EC - Ecuador	1
EG - Egitto	1
GD - Grenada	1
HN - Honduras	1
IE - Irlanda	1
IL - Israele	1
KE - Kenya	1
KW - Kuwait	1
LB - Libano	1
LT - Lituania	1
MA - Marocco	1
NI - Nicaragua	1
PE - Perù	1
PT - Portogallo	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TR - Turchia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.595

Nome	#
Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease	229
Multilayer and MATR3-dependent regulation of mRNAs maintains pluripotency in human induced pluripotent stem cells	214
Epsins regulate mouse embryonic stem cell exit from pluripotency and neural commitment by controlling notch activation	212
Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease	208
Generation and characterization of a human iPSC line from an ALS patient carrying the Q66K-MATR3 mutation	188
Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery	170
Modeling medulloblastoma in vivo and with human cerebellar organoids	161
mSEL-1L deficiency affects vasculogenesis and neural stem cell lineage commitment	160
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient	51
Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids	42
Totale	1.635

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	87	0	0	0	9	0	2	6	32	7	5	7	19
2022/2023	138	14	20	1	25	12	22	1	11	19	7	3	3
2023/2024	61	6	7	1	14	10	8	5	3	0	1	2	4
2024/2025	209	7	2	22	53	6	26	7	11	6	33	18	18
2025/2026	508	36	5	50	62	73	43	96	19	27	42	20	35
2026/2027	180	16	20	50	94	0	0	0	0	0	0	0	0
Totale													1.635